Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma

Hepato-Gastroenterology

Volumn 52, Issue 66, 2005, Pages 1814-1819

  Sasaki, Atsushi ^a   Kawano, Katsunori ^a   Inomata, Masafumi ^a   Shibata, Kohei ^a   Matsumoto, Toshifumi ^a   Kitano, Seigo ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

CA19 9; CEA; Colorectal carcinoma; Extrahepatic metastasis; Liver metastasis

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CARCINOMA; CORRELATION FUNCTION; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; TUMOR;

ADULT; AGE FACTORS; AGED; BIOPSY, NEEDLE; CA-19-9 ANTIGEN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 28544442310     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Kato A, Nakamura S, Omoto H, Nakajima N: Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 1998; 82:274-278.
2. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J, Imamura H: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231:487-499.
3. Bolton JS, Fuhrman GM: Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000; 231:743-751.
4. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235:756-766.
5. Wagman LD, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU: A prospective, randomized evaluation of the treatment if colorectal cancer metastatic to the liver. J Clin Oncol 1990; 8:1885-1893.
6. Kokudo N, Seki M, Ohta H, Azekura K, Ueno M, Sato T, Moroguchi A, Matsubara T, Takahashi T, Nakajima T, Aiba K: Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Ann Surg Oncol 1998; 5:706-712.
7. Lorenz M, Müller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein W, Encke A: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 1998; 228:756-762.
8. Registry of Hepatic Metastases: Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988; 103:278-288.
9. Nordlinger B, Guiguet M, Valiant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D: Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996; 77:1254-1262.
10. Fong Y, Cohen AM, Fortner JG, Enker WE, Turbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF: Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938-946.
11. Sasaki A, Aramaki M, Kawano K, Yasuda K, Inomata M, Kitano S: Prognostic significance of intrahepatic lymphatic invasion in patients with hepatic resection due to metastases from colorectal carcinoma. Cancer 2002; 95:105-111.
12. American Society of Clinical Oncology: Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 1996; 14:2843-2877.
13. Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, Kusashiro K, Furuya S, Nakajima N: Hepatic resection of colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999; 42:632-639.
14. Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K, Maeda T, Kajiyama K, Sugimachi K: Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 1997; 84:1077-1080.
15. Nagashima I, Oka T, Hamada C, Naruse K, Osada T, Muto T: Histopathologic prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer. Am J Gastroenterol 1999; 94:739-743.
16. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H: Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999; 86:332-337.
17. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P: Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genetics 1979; 5:957-972.
18. Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, Ginsburg V: A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentose II. J Biol Chem 1982; 257:14365-14369.
19. Berg EL, Magnani J, Warnock RA, Robinson MK, Butcher EC: Comparison of L-selectin and E-selectin ligand specificities: the L-selectin can bind the E-selectin ligands sialyl Le(x) and sialyl Le(a). Biochem Biophys Res Commun 1992; 184:1048-1055.
20. Ueda T, Shimada E, Urakawa T: The clinicopathologic features of serum CA 19-9-positive colorectal cancer. Jap J Surg 1994; 24:518-522.
21. Kouri M, Pyrhonen S, Kuusela P: Elevated CA 19-9 as the most significant prognostic factor in advanced colorectal carcinoma. J Surg Oncol 1992; 49:78-85.
22. Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CC, Lin TC, Jiang JK, Yang SH, Wang HS, Chen PM: CA 19-9 as the most significant prognostic factor of metastatic colorectal cancer. Hepatogastroenterology 2002; 49:160-164.
23. Gold P, Freedman So: Specific carcinoembryonic antigen of the human digestive system. J Exp Med 1965; 122:467-481.
24. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF: Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978; 299:448-451.
25. Nakajima Y, Nagao M, Ko S, Kanehiro H, Hisanaga M, Aomatsu Y, Ikeda N, Shibaji T, Ogawa S, Nakano H: Clinical predictors of recurrence site after hepatectomy for metastatic colorectal cancer. Hepatogastroenterology 2001; 48:1680-1684.